Background Diagnostic accuracy of reflectance confocal microscopy (RCM) as a stand-alone diagnostic tool for suspect skin lesions has not been extensively studied.
Introduction
Reflectance confocal microscopy (RCM) permits non-invasive acquisition of 'optical sections' of skin with cellular detail and is particularly applicable to examination of melanocytic neoplasms. 1 A meta-analysis 2 of diagnostic accuracy of RCM for melanoma examined five studies composed of 909 lesions [3] [4] [5] [6] [7] and
identified an overall sensitivity of 93% and specificity of 76%. Several studies 3, 5, 6 reported on achieving high diagnostic accuracy, based on RCM reading that was blinded to anamnestic information (other than patients' age and lesions' anatomic location), as well as to dermoscopic and clinical images. Since RCM diagnostic proficiency has a learning curve, beginners using RCM in their practice may seek experts' guidance when encountering difficult lesions. As RCM is a digital imaging technology, experts may consult novices via cloud-based 'tele-RCM'. 8 Further, since RCM produces histopathology-like optical sections of tissue, dermatopathologists may be enrolled as 'tele-RCM' diagnosticians. Notably, dermatopathologists routinely render diagnoses based on 'stand-alone' tissue slides, with clinical description that is lacking or insufficient and in the absence of supplemental clinical images. To this end, the goal of this prospective, multicenter study was to simulate and test tele-RCM diagnosis, with RCM as a stand-alone diagnostic tool. Experts remotely evaluated standardized RCM images of lesions that were suspicious for melanoma, yet clinically and dermoscopically equivocal, and issued management decisions. These readers were provided limited clinical data (age, sex, melanoma history and lesion size and location) and no clinical or dermoscopic lesion images. The principle study aim was to measure experts' accuracy in stand-alone RCM-based management decisions. As secondary aims, we sought to identify attributes that are helpful in reaching the correct diagnosis and to measure readers' interobserver reliability.
Materials and methods

Subjects and lesions
The Institutional Review Boards at Memorial Sloan Kettering Cancer Center, Loma Linda University Medical Center, University of Rochester Medical Center and Western IRB approved the study protocol. Study participants were recruited from patients undergoing skin cancer screening at the aforementioned tertiary medical centres and at a private practice. Inclusion criteria were:
(i) age ≥18 years; (ii) consent for biopsy of lesions clinically and dermoscopically suspicious for melanoma; and (iii) lesions located on anatomical sites amenable to wide-probe RCM imaging. Exclusion criteria were: (i) lesions on acral volar surfaces; (ii) lesion treatment with topical therapies within the past 6 weeks; (iii) peri-lesional skin afflicted with another condition; and (iv) hypersensitivity to RCM adhesive rings. Informed consent was obtained from each participant. Participants were enrolled from 21 August 2008 through 5 January 2010.
Lesion imaging and biopsy protocol
Dermoscopic images were acquired per standard of care at each contributing centre. Study imaging was performed with VivaScope1500 (CaliberI.D., Rochester, NY, USA). Following oil application, a metal ring attached to polycarbonate window was centred on the lesion. A macroscopic image was captured, allowing dermoscopy-guided lesion navigation. Water-based gel was applied over the adhesive window as immersion medium for the RCM probe. Individual RCM images (500 9 500 lm) were sequentially collected in the horizontal X-Y-plane to create 6 9 6 mm mosaic images. To ensure standardized RCM imaging across study sites, a software prompted RCM imaging in specific sequence. RCM imaging consisted of appropriately-sized mosaics that encompassed the entire lesion, up to 6 9 6 mm. If lesion diameter was >6 mm, the ring was centred on the most suspicious area; if heterogeneously coloured, the ring was placed so that images sampled disparate areas of the multi-coloured lesion.
Standard RCM image set included horizontal mosaics captured at the granular-spinous layers, dermal-epidermal junction (DEJ), and superficial dermis. Predefined image stacks -30 images spaced 5 lm apart from stratum corneum to superficial dermis -were obtained from four lesion margins. Three additional image stacks could be captured at the investigator's discretion.
Lesions were biopsied per standard-of-care for each contributing institution. Biopsy specimens were processed at the contributing institution's pathology laboratory and a board-certified dermatopathologist issued a diagnostic report and categorized the lesions as benign, indeterminate or malignant. Indeterminate lesions were those with a differential diagnosis between naevus and melanoma (e.g. 'atypical melanocytic proliferation') or an equivocal diagnosis of naevus (e.g. 'early evolving melanoma in situ cannot be ruled out', 'dysplastic naevus with high-grade atypia and regression').
Evaluation of images
Upon completion of participant enrolment, three readers independently reviewed 100 RCM cases randomly selected from the data set. All included lesions were equivocal for clinical and dermoscopic diagnosis by pigmented lesion experts. RCM readers were experts in diagnostic interpretation of RCM images and had varied professional backgrounds (two clinical dermatologists and one dermatopathologist). For each case, readers received clinical data, including patient's age, sex and melanoma history, as well as lesion size and anatomic location. Readers were blinded to lesion's clinical and dermoscopic photographs, as well as histopathological diagnosis. Readers accessed images via secure RCM image server (VivaNet; CaliberI.D.) and evaluations were entered into standardized study-specific web interface. Each reader was supplied with an imaging workstation and calibrated monitor to assure image display uniformity. Readers received the complete set of RCM images acquired for each case without preselection of images. Readers scored the presence of RCM descriptors (Table S1 ) and management recommendation (biopsy vs. observation). The list of RCM descriptors included terms commonly used in the diagnosis of melanoma and nevi; additional descriptors were included to encompass the possible inclusion of non-melanocytic neoplasms that may clinically mimic melanoma. RCM reader reviews were completed on 21 September 2011.
Statistical analysis
Descriptive statistics were used for study participants, lesions and results of RCM assessments. To measure sensitivity, specificity and diagnostic accuracy, we considered a binary test of management decisions based on RCM analysis; malignant if readers recommended biopsy, or benign if readers recommended observation. Accuracy of RCM-based management decisions was judged against histopathological diagnosis; biopsy was scored as correct for histopathologically malignant or indeterminate lesions, and observation as correct for histopathologically benign lesions.
Given the lack of reference standard for presence or absence of RCM features, overall and reviewer pairwise assessments of RCM feature prevalence, overall percent agreement, kappa and prevalence-adjusted-bias-adjusted-kappa (PABAK) statistics were used to evaluate interobserver agreement. Percent agreement was calculated as sum of concordant positive and negative evaluations divided by sample size. PABAK estimates were used due to the low prevalence of RCM features. PABAK assumes a 50% prevalence and was interpreted as standard kappa statistics as described by Landis and Koch with values <0.4 representing poor agreement, 0.4-0.75 fair to good agreement, and >0.75 excellent agreement.
Logistic regression models were created to assess association between lesion diagnosis and individual RCM features. Analyses were performed as a group, with each RCM reader contributing evaluations and separately, stratified by RCM reader. Standard error estimates for group analyses adjusted for clustered observations within reviewer. Regression models for binary outcomes using general estimating equations approach with a log link and exchangeable correlation structure were utilized. All analyses were performed with Stata v12.1, Stata Corporation, College Station, TX, USA. Primary analyses were performed between January 2012 and December 2014.
Results
One hundred lesions from 92 participants were randomly selected from 439 lesions collected from participating enrolment sites. Sixty-four (64%) participants were male and mean age was 53.8 (range 18-81) years. The histopathological diagnosis for the 100 lesions consisted of 28 malignant neoplasms [23 melanoma, three basal cell carcinoma (BCC) and two squamous cell carcinoma (SCC)], 11 indeterminate melanocytic lesions, and 61 benign lesions (50 naevus, five seborrhoeic keratosis/solar lentigo/lichen planus-like keratosis, thee actinic keratosis (AK), one dermatofibroma, one interface dermatitis, one post-inflammatory pigment alteration).
There were divergent imaging quality assessments among the RCM readers. Reader 1 indicated that 5% of image sets were limited, 4 (4/100, 4%) by image quality and 2 (2%) by insufficient lesion area imaged; Reader 2 indicated sufficient image quality in all cases; while Reader 3 denoted 27% of imaged lesions as limited, 17 (17%) by insufficient lesion area imaged and 12 (12%) by limited image quality.
For management decisions, the sensitivity, specificity and diagnostic accuracy values were 74%, 67% and 70% for reader 1, 46%, 84% and 69% for reader 2 and 72%, 46% and 56% for reader 3, respectively ( Table 1 ). The overall kappa for management decision was 0.34. Of 100 lesions, all three readers agreed on management decisions (biopsy vs. observation) in 50 cases (50%); the pooled sensitivity, specificity and diagnostic accuracy for these RCM unanimously managed lesions were 75.0%, 72.7% and 74.0%, respectively. Because melanocytic neoplasms with indeterminate diagnosis may introduce a misclassification bias in the interpretation of the results, we also calculated diagnostic accuracy for the subset of 89 lesions for which a clear-cut histopathological diagnosis was issued; the sensitivity, specificity and diagnostic accuracy values were 82%, 67% and 72% for reader 1, 57%, 84% and 75% for reader 2 and 79%, 46% and 56% for reader 3, respectively.
The prevalence of RCM features as observed by the readers is presented ( Table 2 ). Prevalence of RCM features identified by all three readers ranged from 1% to 37% for the evaluated lesions, with most features being observed in <20% of lesions. Interobserver agreement measures -percent agreement and prevalence-adjusted-bias-adjusted-kappa (PABAK) values -are also presented ( Table 2 ).
The reader-specific association between diagnosis and RCM features based on univariate logistic regression was analysed. First, since the study set of lesions that were clinically suspected of being melanoma included non-melanocytic neoplasms, we calculated the association between RCM features and malignant (melanoma, indeterminate melanocytic neoplasms, BCC and SCC) vs. benign diagnosis for all 100 study lesions (Table 3) ; notably, AK was classified as benign in this analysis. Epidermal infiltration by cells in Pagetoid pattern, nonspecific architecture and abnormal vasculature were associated with malignant diagnosis for two readers. In addition, coarse collagen fibres and streaming of nuclei were associated with malignant diagnosis for all three readers.
To identify melanoma-specific RCM features, we calculated the association between RCM features and diagnosis for the subset of 73 melanocytic neoplasms with unequivocal histopathological diagnosis, including 23 melanomas and 50 nevi (Table 4) ; none of the features were associated with melanoma in the evaluation of all three readers. However, nonspecific architecture, non-visible papillae, streaming of nuclei, coarse collagen fibres and abnormal vasculature showed a significant association with melanoma in the evaluation of two of three readers. Notably, infiltration in Pagetoid pattern showed nearly significant association with melanoma in the evaluation of all three readers. 
Discussion
In this study, three experts, simulating tele-RCM consultants, independently evaluated RCM images of equivocal skin lesions.
As the primary aim, we measured accuracy based on experts' management recommendations, judged against the reference standard of histopathological diagnosis. The accuracy ranged between 56% and 70%, with a sensitivity of 46-74% and a specificity of 46-84%. Our findings suggest that at the current level of RCM diagnostic expertise, the procedure has limitations as a stand-alone diagnostic tool in the absence of clinical or dermoscopic images.
The diagnostic accuracy measured in our study is notably lower than in other RCM studies. Rao et al. 9 evaluated accuracy of RCM reading of 334 lesions by an onsite and a remote reader. Evaluated sets included both dermoscopic and RCM images. Single-reader sensitivity was >90% and specificity was >60%. Ludzik et al. 10 retrospectively evaluated 100 equivocal cases with combined dermoscopy-RCM image sets and found single-reader sensitivity of 89% and specificity of 66%. Witkowski et al. 11 had 10 readers retrospectively evaluate 1000 combined dermoscopy-RCM image sets and found single-reader sensitivity of 95% and specificity of 76%. Several factors may have contributed to our results. First, most prior studies included dermoscopy images and readers who were proficient in both dermoscopy and RCM. At the bedside, pretest probability for RCM diagnosis is already narroweddown by a skilled clinician's differential diagnosis (e.g. BCC vs. intradermal naevus), and in such cases, RCM can greatly enhance diagnostic accuracy. In addition to informing the interpretation of RCM readers, dermoscopy and RCM expertise may have influenced selection of RCM stacks during image acquisition process in prior studies. In practice, to attain high sensitivity in melanoma diagnosis, proficiency in dermoscopy and RCM should be regarded as complementary; RCM testing results need to be reconciled with the overall clinical and dermoscopic judgment. 12, 13 For example, Guitera et al. 14 have shown that for light-coloured lesions, sensitivity for melanoma diagnosis of combined dermoscopy-RCM is higher than RCM alone. Our rationale for blinding the readers was that tele-RCM experts might be dermatopathologists who routinely make stand-alone histopathological diagnosis, and who may lack clinical and dermoscopic diagnostic expertise. Second, lesions included in the study may have been more difficult for diagnosis than in prior studies. The data set consisted of lesions that were suspicious for melanoma and equivocal to clinical and dermoscopic diagnosis in the hands of pigmented lesions experts. Notably, 40% of lesions came from a clinic that largely treats older patients with severely sundamaged skin. In our experience, evaluators who do not routinely examine skin lesions on severely sun-damaged skin experience a decline in specificity by dermoscopy or RCM in this setting. This observation is reiterated by the fact that 9/11 (82%) of the lesions whose histopathological diagnosis was 'indeterminate' also originated from this clinic.
While if taken at face value, the diagnostic accuracy and interobserver agreement in our study seems concerning, it is important to note that the gold standard of histopathology that we applied has its own limitations. These limitations have led to a recent concerted effort to create a simplified, clinically relevant ontology of histopathological diagnosis of melanocytic tumours termed M-Path. 15, 16 However, even with this simplified schema, interobserver agreement for 'type 3' lesions (e.g. melanoma in situ) among experienced pathologists was 40%. 17 Considering we are relatively early on the learning curve of RCM interpretation, our results can be seen as encouraging and suggest that lessons learned from pathology should be applied. First, the level of pathologists' accuracy and concordance for diagnosis of melanocytic neoplasms significantly increases when pertinent clinical data becomes available (e.g. clinician's diagnosis and dermoscopic images). 18 Second, case-selection can affect diagnostic concordance. In a study of 1249 clinically equivocal melanocytic neoplasms, interobserver agreement among pathologists was markedly lower for patients with clinically atypical moles (kappa=0.31) compared to patients without clinically atypical moles (kappa = 0.76). 19 Finally agreement between experts can increase with time. For example, interobserver agreement on presence of ulceration and mitotic rate in melanomas improved over a 10-year period. 20 In addition to measuring accuracy, we secondarily aimed at identifying key RCM criteria that help differentiate melanoma from benign neoplasms and to understand whether different RCM readers can recognize these key criteria in a reproducible fashion. For this analysis, we focused on melanocytic neoplasms that were issued an unequivocal diagnosis of melanoma or naevus. We found some criteria that correlated with the diagnosis of melanoma and that had fair interobserver agreement. Nonspecific architecture, non-visible papillae, coarse collagen fibres, abnormal vasculature and streaming of nuclei showed a significant association with melanoma in evaluation by two of three RCM readers; these criteria also showed fair-to-good interobserver agreement. In addition, epidermal infiltration by cells in a Pagetoid pattern displayed a nearly significant association with melanoma; however, this RCM criterion showed poor interobserver agreement.
New criteria emerged as potentially useful and reproducible for the diagnosis of melanoma. Nonspecific architecture and non-visible papillae at the DEJ level (Fig. S1) , and abnormal vasculature (Fig. S2a) and coarse collagen fibres (Fig. S2b) at the superficial dermis level, were significantly associated with the diagnosis of melanoma in the evaluation of two of the readers and attained fair-to-good interobserver agreement. Nonspecific architecture seen at 'low-magnification' mosaic view, and nonvisible papillae seen at 'high-magnification' optical section view, denote disruption or loss of the undulating DEJ pattern due to flattening of the retes (Fig. S1) . 21 Coarse collagen fibres likely correlate in some cases with solar elastosis. 22 In other cases, the abnormal collagen seen under RCM is probably related to stromal remodelling in melanoma. These findings support previous dermoscopic observations. 23, 24 The presence of abnormal collagen, seen under polarized dermoscopy as white shiny lines, is 10-fold more frequent among melanomas than nevi. 25 The presence of dermoscopically identified polymorphous blood vessels is also more frequent among melanomas than nevi. 26 Finally, streaming of nuclei has been attributed to the diagnosis of BCC; however, two of the readers identified this feature in melanomas during blinded evaluations, but could not account for this finding in retrospective examination. The utility of this feature requires further study. Our study has limitations. First, the study is based on a limited number of lesions. Second, our methodology risks RCM misclassification of lesions>6 mm in diameter due to subjective selection of the focus of interest within the lesion. Third, the study uses histopathological diagnosis, and not biological outcome, as reference standard; subsequently, 11% of the data set was histopathologically classified as indeterminate. Fourth, there was variability in perception of image quality -one reader marked a fourth of images as limited in quality. This may be due to a learning curve in the training of RCM technicians or due to a decreased confidence level of this reader in the blinded setting, leading to a higher expected image quality standard. Fifth, a substantial fraction of melanomas consisted of melanomas arising on sun-damaged skin. Pellacani et al. 27 have reported variability in RCM criteria between different subtypes of melanoma. Thus, our results may not be generalizable to populations composed of different proportions of melanoma subtypes. Finally, despite utilizing a uniform feature-set, readers appeared to be giving different diagnostic weight to features. Readers may have also uniquely recognized additional RCM findings, not listed in the reportable set. These interpreter variations were likely diagnostically advantageous in certain cases and distracting in others.
In conclusion, our data suggest that RCM tele-consultation of especially challenging lesions, based on image review without benefit of clinical or dermoscopy images, may be associated with limited diagnostic accuracy and interobserver agreement. We suggest that supplementation of the standardized image acquisition with stacks from sites deemed concerning by the technician, along with inclusion of clinical and dermoscopy images to benefit interpretation by reviewers, will improve diagnostic accuracy. Moreover, our data support the need for formal RCM courses with integrated dermoscopic and histopathological training. As with the ongoing efforts in histopathology, a simplified, clinically relevant ontology of diagnostic categories and shared training in image interpretation should improve both diagnostic accuracy and reproducibility. To this end, our data suggest that upon further study, architectural and stromal RCM criteria may emerge as potentially useful and reproducible criteria for diagnosis of melanoma.
